DownloadHi-Res Photo

Helen Parise, ScD

Associate Professor Adjunct

Research & Publications
Biography
News

Coauthors

Selected Publications

Long-term outcomes of patients with ischemia and no obstructive coronary artery disease (INOCA) - a systematic review and meta-analysisOdanovic N, Schwann A, Zhang Z, Kapadia S, Kunnirickal S, Parise H, Tirziu D, Ilic I, Lansky A, Pietras C, Shah S. Long-term outcomes of patients with ischemia and no obstructive coronary artery disease (INOCA) - a systematic review and meta-analysis. European Heart Journal 2023, 44: ehad655.1216. DOI: 10.1093/eurheartj/ehad655.1216.
Predictors of Cerebral Embolic Debris During Transcatheter Aortic Valve Replacement: The SafePass 2 First-in-Human StudyGrubman D, Ahmad Y, Leipsic J, Blanke P, Pasupati S, Webster M, Nazif T, Parise H, Lansky A. Predictors of Cerebral Embolic Debris During Transcatheter Aortic Valve Replacement: The SafePass 2 First-in-Human Study. The American Journal Of Cardiology 2023, 207: 28-34. PMID: 37722198, DOI: 10.1016/j.amjcard.2023.08.137.
Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications.Pathak A, Rudolph U, Saxena M, Zeller T, Müller-Ehmsen J, Lipsic E, Schmieder R, Sievert H, Halbach M, Sharif F, Parise H, Fischell T, Weber M, Kandzari D, Mahfoud F. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications. EuroIntervention 2023, 19: 602-611. PMID: 37427416, PMCID: PMC10493775, DOI: 10.4244/eij-d-23-00088.
Supervised Exercise Therapy Versus Percutaneous Transluminal Angioplasty for Claudication by Level of Disease: A Systematic Review and Meta-AnalysisKapadia S, Huang H, Parise H, Ismayl M, Ahmed Z, Tirziu D, Altin S. Supervised Exercise Therapy Versus Percutaneous Transluminal Angioplasty for Claudication by Level of Disease: A Systematic Review and Meta-Analysis. The American Journal Of Cardiology 2023, 205: 403-405. PMID: 37659260, DOI: 10.1016/j.amjcard.2023.08.044.
Effect of antecedent statin usage on conduction disturbances and arrhythmias after transcatheter aortic valve replacementShah T, Maarek R, See C, Huang H, Wang Y, Parise H, Forrest J, Lansky A. Effect of antecedent statin usage on conduction disturbances and arrhythmias after transcatheter aortic valve replacement. Cardiovascular Revascularization Medicine 2023, 59: 3-8. PMID: 37573173, DOI: 10.1016/j.carrev.2023.07.022.
Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent ClaudicationAltin S, Parise H, Hess C, Rosenthal N, Creager M, Aronow H, Curtis J. Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication. JACC Cardiovascular Interventions 2023, 16: 1668-1678. PMID: 37438035, DOI: 10.1016/j.jcin.2023.05.001.
Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Diabetes: The Chocolate Touch Study.Böhme T, Zeller T, Shishehbor M, Werner M, Brodmann M, Parise H, Holden A, Lichtenberg M, Parikh S, Kashyap V, Pietras C, Tirziu D, Beschorner U, Krishnan P, Niazi K, Wali A, Lansky A. Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Diabetes: The Chocolate Touch Study. Journal Of Endovascular Therapy 2023, 15266028231179589. PMID: 37314243, DOI: 10.1177/15266028231179589.
Impact of New-Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single-Center StudySee C, Wang Y, Huang H, Parise H, Yang Y, Tirziu D, Francese D, Papoutsidakis N, Bader E, Kaple R, Cleman M, Lansky A, Forrest J. Impact of New-Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single-Center Study. Journal Of Interventional Cardiology 2023, 2023: 5390338. PMID: 37292113, PMCID: PMC10247319, DOI: 10.1155/2023/5390338.
Cerebral Embolic Risk in Coronary and Structural Heart Interventions: Clinical EvidenceTirziu D, Huang H, Parise H, Pietras C, Moses J, Messé S, Lansky A. Cerebral Embolic Risk in Coronary and Structural Heart Interventions: Clinical Evidence. Journal Of The Society For Cardiovascular Angiography & Interventions 2023, 2: 100631. DOI: 10.1016/j.jscai.2023.100631.
Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trialShah T, McCarthy M, Nasir I, Archer H, Ragheb E, Kluger J, Kashyap N, Paredes C, Patel P, Lu J, Kandel P, Song C, Khan M, Huang H, Haq F, Ahmad R, Howes C, Cambi B, Lancaster G, Cleman M, Dela Cruz C, Parise H, Lansky A. Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial. BMJ Open 2023, 13: e067910. PMID: 36828654, PMCID: PMC9971831, DOI: 10.1136/bmjopen-2022-067910.
Abstract 11232: Coronary Artery Bypass Graft Surgery Shows Improved Restricted Mean Survival Time and Time Lost Compared to Medical Therapy in Patients With Left Ventricular Dysfunction: From the STICH TrialReinhardt S, Huang H, Parise H, Ahmad T, Velazquez E, Faridi K. Abstract 11232: Coronary Artery Bypass Graft Surgery Shows Improved Restricted Mean Survival Time and Time Lost Compared to Medical Therapy in Patients With Left Ventricular Dysfunction: From the STICH Trial. Circulation 2022, 146: a11232-a11232. DOI: 10.1161/circ.146.suppl_1.11232.
Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset AnalysisLansky AJ, Tirziu D, Moses JW, Pietras C, Ohman EM, O'Neill WW, Ekono MM, Grines CL, Parise H. Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis. The American Journal Of Cardiology 2022, 185: 29-36. PMID: 36210212, DOI: 10.1016/j.amjcard.2022.08.032.
Coronary Orbital Atherectomy in Patients With Severe Aortic Stenosis.Donatelle M, Agasthi P, Parise H, Igyarto Z, Martinsen B, Leon M, Beohar N. Coronary Orbital Atherectomy in Patients With Severe Aortic Stenosis. Journal Of Invasive Cardiology 2022, 34: e696-e700. PMID: 36200995.
TCT-209 Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Patients With Diabetes Mellitus: Results of the Randomized Chocolate Touch StudyParikh S, Zeller T, Shishehbor M, Werner M, Brodmann M, Parise H, Holden A, Lichtenberg M, Kashyap V, Pietras C, Tirziu D, Ardakani S, Beschorner U, Krishnan P, Niazi K, Wali A, Lansky A. TCT-209 Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Patients With Diabetes Mellitus: Results of the Randomized Chocolate Touch Study. Journal Of The American College Of Cardiology 2022, 80: b84. DOI: 10.1016/j.jacc.2022.08.246.
Coronary Orbital Atherectomy Treatment of Hispanic and Latino Patients: A Real-World Comparative AnalysisBeohar N, Stone G, Martinsen B, Parise H, Vinardell J, Heimowitz T, Koelbl C, Leon M, Kirtane A. Coronary Orbital Atherectomy Treatment of Hispanic and Latino Patients: A Real-World Comparative Analysis. Cardiovascular Revascularization Medicine 2022, 40: 14. DOI: 10.1016/j.carrev.2022.06.021.
Impact of drug adherence on blood pressure response to alcohol-mediated renal denervationPersu A, Maes F, Toennes S, Ritscher S, Georges C, Wallemacq P, Haratani N, Parise H, Fischell T, Lauder L, Mahfoud F. Impact of drug adherence on blood pressure response to alcohol-mediated renal denervation. Blood Pressure 2022, 31: 109-117. PMID: 35575248, DOI: 10.1080/08037051.2022.2074367.
Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study)Shishehbor MH, Zeller T, Werner M, Brodmann M, Parise H, Holden A, Lichtenberg M, Parikh SA, Kashyap VS, Pietras C, Tirziu D, Ardakani S, Beschorner U, Krishnan P, Niazi KA, Wali AU, Lansky AJ. Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study). Circulation 2022, 145: 1645-1654. PMID: 35377157, DOI: 10.1161/circulationaha.122.059646.
Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real‐world comparative analysisBeohar N, Stone G, Martinsen B, Parise H, Vinardell J, Heimowitz T, Koelbl C, Leon M, Kirtane A. Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real‐world comparative analysis. Catheterization And Cardiovascular Interventions 2022, 99: 1752-1757. PMID: 35312163, PMCID: PMC9540752, DOI: 10.1002/ccd.30158.
CLINICAL PREDICTORS OF EMBOLIC BURDEN AFTER TAVR: AN ANALYSIS OF THE SAFEPASS 2 CLINICAL STUDYLansky A, White J, Stewart J, Blake J, Smyth D, Pasupati S, Nair R, Parise H, Pietras C, Webster M, Kawakami R, Virmani R, Leipsic J. CLINICAL PREDICTORS OF EMBOLIC BURDEN AFTER TAVR: AN ANALYSIS OF THE SAFEPASS 2 CLINICAL STUDY. Journal Of The American College Of Cardiology 2022, 79: 628. DOI: 10.1016/s0735-1097(22)01619-9.
Off-Label Use of Balloon Mitral Valvuloplasty in Nonrheumatic Mitral Stenosis With Severe Mitral Annular CalcificationDonatelle M, Patel R, Agasthi P, Parise H, Leon M, Mihos C, Beohar N. Off-Label Use of Balloon Mitral Valvuloplasty in Nonrheumatic Mitral Stenosis With Severe Mitral Annular Calcification. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 1: 100026. DOI: 10.1016/j.jscai.2022.100026.
DAYS ALIVE OUT OF HOSPITAL FOR PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AND CORONARY ARTERY DISEASE TREATED WITH CORONARY ARTERY BYPASS SURGERY OR MEDICAL THERAPY: FINDINGS FROM THE STICH TRIALFaridi K, Huang H, Parise H, Ahmad T, Mori M, Chung M, Yeh R, Velazquez E. DAYS ALIVE OUT OF HOSPITAL FOR PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AND CORONARY ARTERY DISEASE TREATED WITH CORONARY ARTERY BYPASS SURGERY OR MEDICAL THERAPY: FINDINGS FROM THE STICH TRIAL. Journal Of The American College Of Cardiology 2022, 79: 1058. DOI: 10.1016/s0735-1097(22)02049-6.
Implementation of supervised exercise therapy in a veteran population with symptomatic claudicationAltin S, Schneider MD, Parise H, Banerjee S, Wu WC, Meadows JL, Pfau S, Keefe H, Armstrong EJ. Implementation of supervised exercise therapy in a veteran population with symptomatic claudication. Vascular Medicine 2022, 27: 136-141. PMID: 35225695, DOI: 10.1177/1358863x211073622.
TCT-118 Propensity-Adjusted Population-Based Analysis of Impella in Patients Undergoing High-Risk PCI From a Large-Scale Claims DatasetLansky A, Tirziu D, Pietras C, Moses J, Ohman E, O'Neill W, Grines C, Needham K, Ekono M, Gregory D, Parise H. TCT-118 Propensity-Adjusted Population-Based Analysis of Impella in Patients Undergoing High-Risk PCI From a Large-Scale Claims Dataset. Journal Of The American College Of Cardiology 2021, 78: b49-b50. DOI: 10.1016/j.jacc.2021.09.968.
TCT-443 Short-Term Outcomes of Orbital Mechanical Atherectomy in Patients With Severe Aortic StenosisDonatelle M, Agasthi P, Parise H, Kirtane A, Leon M, Beohar N. TCT-443 Short-Term Outcomes of Orbital Mechanical Atherectomy in Patients With Severe Aortic Stenosis. Journal Of The American College Of Cardiology 2021, 78: b181-b182. DOI: 10.1016/j.jacc.2021.09.1296.
TCT CONNECT-165 Orbital Atherectomy for Treating De Novo, Severely Calcified Coronary Lesions: A Tertiary Center ExperienceVinardell J, Podesta C, Mohammed N, Heimowitz T, Koelbl C, Parise H, Kirtane A, Beohar N. TCT CONNECT-165 Orbital Atherectomy for Treating De Novo, Severely Calcified Coronary Lesions: A Tertiary Center Experience. Journal Of The American College Of Cardiology 2020, 76: b71. DOI: 10.1016/j.jacc.2020.09.177.
Evaluation of Transcatheter Alcohol-Mediated Perivascular Renal Denervation to Treat Resistant HypertensionJanas A, Król M, Hochuł M, Jochymczyk M, Hayward-Costa C, Parise H, Haratani N, Fischell T, Wojakowski W. Evaluation of Transcatheter Alcohol-Mediated Perivascular Renal Denervation to Treat Resistant Hypertension. Journal Of Clinical Medicine 2020, 9: 1881. PMID: 32560164, PMCID: PMC7356226, DOI: 10.3390/jcm9061881.
CHEMICAL RENAL DENERVATION WITH ALCOHOL – THE POST-MARKET STUDY MEDICATION ADHERENCE DATAPersu A, Toennes S, Ritscher S, Georges C, Wallemacq P, Haratani N, Parise H, Fischell T, Lauder L, Mahfoud F. CHEMICAL RENAL DENERVATION WITH ALCOHOL – THE POST-MARKET STUDY MEDICATION ADHERENCE DATA. Journal Of Hypertension 2019, 37: e283. DOI: 10.1097/01.hjh.0000573612.55841.28.
IN-HOSPITAL OUTCOMES AFTER TRANSCATHETER EDGE-TO-EDGE MITRAL VALVE REPAIR IN PATIENTS WITH CHRONIC KIDNEY DISEASE: AN ANALYSIS FROM THE 2012-2015 NATIONAL INPATIENT SAMPLEPanchal H, Stone G, Parise H, Davidson C, Leon M, Nagabandi A, Beohar N. IN-HOSPITAL OUTCOMES AFTER TRANSCATHETER EDGE-TO-EDGE MITRAL VALVE REPAIR IN PATIENTS WITH CHRONIC KIDNEY DISEASE: AN ANALYSIS FROM THE 2012-2015 NATIONAL INPATIENT SAMPLE. Journal Of The American College Of Cardiology 2019, 73: 1180. DOI: 10.1016/s0735-1097(19)31787-5.
Changes in Wave Reflection With Advancing Age in Normal SubjectsMitchell G, Parise H, Benjamin E, Larson M, Keyes M, Vita J, Vasan R, Levy D. Changes in Wave Reflection With Advancing Age in Normal Subjects. Hypertension 2019, 44: e10-e11. DOI: 10.1161/01.hyp.0000146404.12432.a2.
TCT-365 Contemporary Outcomes in No-Option Chronic Critical Limb Ischemia: A Systematic Review and Meta-AnalysisGhare M, Pietras C, Tirziu D, Tsay C, Parise H, White R, Lansky A. TCT-365 Contemporary Outcomes in No-Option Chronic Critical Limb Ischemia: A Systematic Review and Meta-Analysis. Journal Of The American College Of Cardiology 2018, 72: b148. DOI: 10.1016/j.jacc.2018.08.1517.
TCT-562 Chemical Renal Denervation With Alcohol – The Post-Market Study Data And The Target BP ProgramMahfoud F, Ewen S, Persu A, Renkin J, Wojakowski W, Schmieder R, van der Giet M, de Bucourt M, Zirlik A, Haratani N, Parise H, Fischell T, Bertog S, Sievert K, Sievert H. TCT-562 Chemical Renal Denervation With Alcohol – The Post-Market Study Data And The Target BP Program. Journal Of The American College Of Cardiology 2018, 72: b225-b226. DOI: 10.1016/j.jacc.2018.08.1751.
CHEMICAL RENAL DENERVATION WITH ALCOHOL – LONG TERM RESULTS FROM THE PEREGRINE POST-MARKET STUDYPersu A, Renkin J, Hochul M, Wojakowski W, Böhm M, Mahfoud F, Schmieder R, van der Giet M, de Bucourt M, Zirlik A, Neuzil P, Haratani N, Parise H, Fischell T, Bertog S, Sievert K, Sievert H. CHEMICAL RENAL DENERVATION WITH ALCOHOL – LONG TERM RESULTS FROM THE PEREGRINE POST-MARKET STUDY. Journal Of Hypertension 2018, 36: e123. DOI: 10.1097/01.hjh.0000539319.18701.45.
CRT-200.21 Alcohol-mediated Renal Denervation to Treat Hypertension- The Peregrine Post-market StudyBertog S, Sievert H, Hochul M, Wojakowski W, Renkin J, Persu A, Schmieder R, Van der Giet M, De BuCourt M, Zirlik A, Neuzil P, Haratani N, Parise H, Fischell T, Mahfoud F. CRT-200.21 Alcohol-mediated Renal Denervation to Treat Hypertension- The Peregrine Post-market Study. JACC Cardiovascular Interventions 2018, 11: s32-s33. DOI: 10.1016/j.jcin.2018.01.104.
Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2Peguero J, Presti S, Issa O, Podesta C, Parise H, Layka A, Brenes J, Lamelas J, Lamas G. Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2. American Heart Journal 2016, 177: 153-159. PMID: 27297861, DOI: 10.1016/j.ahj.2016.04.019.
GENDER DISPARITIES IN ST-ELEVATION MYOCARDIAL INFARCTION CARE AND OUTCOMES IN EMERGING COUNTRIES: A GLOBAL LUMEN ORGANIZATION FOR WOMEN (GLOW) INITIATIVE AND CALL TO ACTIONLee H, Lansky A, Mehta S, Haimi I, Salwan R, Zambahari R, Chen Y, Hassan F, Parise H, Fasila M, Kontsevaya A, Cheem T, Baumbach A, Granger C, Grines C, Jacobs A, Tresukosol D, Soerianata S, Dy T. GENDER DISPARITIES IN ST-ELEVATION MYOCARDIAL INFARCTION CARE AND OUTCOMES IN EMERGING COUNTRIES: A GLOBAL LUMEN ORGANIZATION FOR WOMEN (GLOW) INITIATIVE AND CALL TO ACTION. Journal Of The American College Of Cardiology 2016, 67: 2356. DOI: 10.1016/s0735-1097(16)32357-9.
CRT-200.92 Gender Disparities in ST-Elevation Myocardial Infarction Care and Outcomes in Emerging Countries: A Global Lumen Organization for Women (GLOW) Initiative and Call to ActionHaimi I, Lee H, Mehta S, Salwan R, Zambahari R, Chen Y, Hassan F, Parise H, Gosh J, Fasila M, Kontsevaya A, Sobhy M, Cheem T, Baumbach A, Henry T, Granger C, Grines C, Jacobs A, Tresukosol D, Soerianata S, Dy T, Lansky A. CRT-200.92 Gender Disparities in ST-Elevation Myocardial Infarction Care and Outcomes in Emerging Countries: A Global Lumen Organization for Women (GLOW) Initiative and Call to Action. JACC Cardiovascular Interventions 2016, 9: s31. DOI: 10.1016/j.jcin.2015.12.124.
Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical TrialCosta R, Abizaid A, Mehran R, Schofer J, Schuler G, Hauptmann K, Magalhães M, Parise H, Grube E, Investigators B. Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial. JACC Cardiovascular Interventions 2016, 9: 51-64. PMID: 26762911, DOI: 10.1016/j.jcin.2015.09.008.
Clinical and Angiographic Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent in Japanese PatientsSaito S, Maehara A, Vlachojannis G, Parise H, Mehran R. Clinical and Angiographic Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent in Japanese Patients. Circulation Journal 2014, 79: 96. PMID: 25428602, DOI: 10.1253/circj.cj-14-0836.
Body Mass Index and Acute and Long-Term Outcomes After Acute Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial)Herrmann J, Gersh B, Goldfinger J, Witzenbichler B, Guagliumi G, Dudek D, Kornowski R, Brener S, Parise H, Fahy M, McAndrew T, Stone G, Mehran R. Body Mass Index and Acute and Long-Term Outcomes After Acute Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). The American Journal Of Cardiology 2014, 114: 9-16. PMID: 24846807, DOI: 10.1016/j.amjcard.2014.03.057.
BIVALIRUDIN VERSUS HEPARIN WITH OR WITHOUT GLYCOPROTEIN IIB/IIIA INHIBITORS IN STEMI PATIENTS UNDERGOING PRIMARY PCI: A POOLED ANALYSIS OF PATIENT-LEVEL DATA FROM THE HORIZONS-AMI AND EUROMAX TRIALSSteg P, Mehran R, Goldstein P, Witzenbichler B, Hof A, Guagliumi G, Hamm C, Genereux P, Clemmensen P, Parise H, Pocock S, Gersh B, Bernstein D, Deliargyris E, Stone G, Bichat H. BIVALIRUDIN VERSUS HEPARIN WITH OR WITHOUT GLYCOPROTEIN IIB/IIIA INHIBITORS IN STEMI PATIENTS UNDERGOING PRIMARY PCI: A POOLED ANALYSIS OF PATIENT-LEVEL DATA FROM THE HORIZONS-AMI AND EUROMAX TRIALS. Journal Of The American College Of Cardiology 2014, 63: a34. DOI: 10.1016/s0735-1097(14)60034-6.
TWO-YEAR CLINICAL OUTCOMES OF SECOND GENERATION VERSUS FIRST GENERATION CORONARY DRUG-ELUTING STENTS: AN ANALYSIS FROM ADAPT-DESParikh P, Kirtane A, Weisz G, Stuckey T, Xu K, Witzenbichler B, Rinaldi M, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Mazzaferri E, Cristea E, Parise H, Mehran R, Stone G. TWO-YEAR CLINICAL OUTCOMES OF SECOND GENERATION VERSUS FIRST GENERATION CORONARY DRUG-ELUTING STENTS: AN ANALYSIS FROM ADAPT-DES. Journal Of The American College Of Cardiology 2014, 63: a1896. DOI: 10.1016/s0735-1097(14)61899-4.
IMPACT OF HEMODIALYSIS AND HIGH PLATELET REACTIVITY ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDYRubin G, Kirtane A, Weisz G, Baber U, Xu K, Parise H, Stuckey T, Witzenbichler B, Rinaldi M, Neumann F, Metzger C, Henry T, Cox D, Duffy P, Brodie B, Mazzaferri E, Mehran R, Stone G. IMPACT OF HEMODIALYSIS AND HIGH PLATELET REACTIVITY ON OUTCOMES FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY. Journal Of The American College Of Cardiology 2014, 63: a1873. DOI: 10.1016/s0735-1097(14)61876-3.
IMPACT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY AFTER CORONARY ANGIOGRAPHY OR PERCUTANEOUS CORONARY INTERVENTION ON LONG-TERM OUTCOMES: A POOLED ANALYSIS FROM THE HORIZONS-AMI AND ACUITY TRIALSGiacoppo D, Mehran R, Bansilal S, Witzenbichler B, Dangas G, Kirtane A, Parise H, Kornowski R, Brener S, Genereux P, Stone G. IMPACT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY AFTER CORONARY ANGIOGRAPHY OR PERCUTANEOUS CORONARY INTERVENTION ON LONG-TERM OUTCOMES: A POOLED ANALYSIS FROM THE HORIZONS-AMI AND ACUITY TRIALS. Journal Of The American College Of Cardiology 2014, 63: a1678. DOI: 10.1016/s0735-1097(14)61681-8.
Impact of Coronary Lesion Complexity on Drug-Eluting Stent Outcomes in Patients With and Without Diabetes Mellitus Analysis From 18 Pooled Randomized TrialsKedhi E, Généreux P, Palmerini T, McAndrew T, Parise H, Mehran R, Dangas G, Stone G. Impact of Coronary Lesion Complexity on Drug-Eluting Stent Outcomes in Patients With and Without Diabetes Mellitus Analysis From 18 Pooled Randomized Trials. Journal Of The American College Of Cardiology 2014, 63: 2111-2118. PMID: 24632279, DOI: 10.1016/j.jacc.2014.01.064.
Comparative effectiveness of upstream glycoprotein IIb/IIIa inhibitors in patients with moderate- and high-risk acute coronary syndromes: An Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudyNazif T, Mehran R, Lee E, Fahy M, Parise H, Stone G, Kirtane A. Comparative effectiveness of upstream glycoprotein IIb/IIIa inhibitors in patients with moderate- and high-risk acute coronary syndromes: An Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy. American Heart Journal 2013, 167: 43-50. PMID: 24332141, DOI: 10.1016/j.ahj.2013.10.013.
Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trialDizon J, Brener S, Maehara A, Witzenbichler B, Biviano A, Godlewski J, Parise H, Dambrink J, Mehran R, Gibson C, Stone G. Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial. European Heart Journal Acute Cardiovascular Care 2013, 3: 78-83. PMID: 24562806, PMCID: PMC3932776, DOI: 10.1177/2048872613508658.
TCT-152 Is There a Therapeutic Window For Platelet Responsiveness Among PCI Patients? Analysis from the ADAPT-DES StudyKirtane A, Stuckey T, Xu K, Witzenbichler B, Weisz G, Rinaldi M, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Mazzaferri E, Cristea E, Parise H, Mehran R, Stone G. TCT-152 Is There a Therapeutic Window For Platelet Responsiveness Among PCI Patients? Analysis from the ADAPT-DES Study. Journal Of The American College Of Cardiology 2013, 62: b48-b49. DOI: 10.1016/j.jacc.2013.08.885.
TCT-68 Does IVUS Reduce Stent Thrombosis with DES? Two-year results from the prospective, multicenter ADAPT-DES studyMaehara A, Weisz G, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Stuckey T, Mazzaferri E, Xu K, Mehran R, Parise H, Mintz G, Stone G. TCT-68 Does IVUS Reduce Stent Thrombosis with DES? Two-year results from the prospective, multicenter ADAPT-DES study. Journal Of The American College Of Cardiology 2013, 62: b21-b22. DOI: 10.1016/j.jacc.2013.08.802.
TCT-403 Impact of Bifurcation Lesion Treatment with DES on Clinical Outcomes: Results from the Prospective, Multicenter ADAPT-DES StudyWitzenbichler B, Brodie B, Cox D, Duffy P, Henry T, Kirtane A, Mazzaferri E, Mehran R, Metzger D, Neumann F, Parise H, Stone G, Stuckey T, Weisz G, Xu K. TCT-403 Impact of Bifurcation Lesion Treatment with DES on Clinical Outcomes: Results from the Prospective, Multicenter ADAPT-DES Study. Journal Of The American College Of Cardiology 2013, 62: b126. DOI: 10.1016/j.jacc.2013.08.1143.
TCT-6 Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results from the ADAPT-DES RegistryBaber U, Mehran R, Kirtane A, Gurbel P, Christodoulidis G, Witzenbichler B, Weisz G, Metzger D, Henry T, Cox D, Duffy P, Mazzaferri E, Xu K, Parise H, Brodie B, Stuckey T, Stone G. TCT-6 Prevalence and Impact of High Platelet Reactivity in Chronic Kidney Disease: Results from the ADAPT-DES Registry. Journal Of The American College Of Cardiology 2013, 62: b3. DOI: 10.1016/j.jacc.2013.08.733.
TCT-155 The Interaction Between Clopidogrel and Calcium Channel Blockers on Platelet Reactivity and Long-Term Events after PCIWeisz G, Kirtane A, Xu K, Stuckey T, Witzenbichler B, Rinaldi M, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Mazzaferri E, Parise H, Mehran R, Stone G. TCT-155 The Interaction Between Clopidogrel and Calcium Channel Blockers on Platelet Reactivity and Long-Term Events after PCI. Journal Of The American College Of Cardiology 2013, 62: b49-b50. DOI: 10.1016/j.jacc.2013.08.888.
TCT-1 Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DESWeisz G, Kirtane A, Xu K, Stuckey T, Witzenbichler B, Rinaldi M, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Mazzaferri E, Parise H, Mehran R, Stone G. TCT-1 Do Proton Pump Inhibitors Interact With Clopidogrel? Insights From ADAPT-DES. Journal Of The American College Of Cardiology 2013, 62: b1. DOI: 10.1016/j.jacc.2013.08.728.
TCT-19 The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes MellitusKedhi E, Genereux P, Palmerini T, McAndrew T, Parise H, Dangas G, Mehran R, Ben-Yehuda O, Stone G. TCT-19 The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus. Journal Of The American College Of Cardiology 2013, 62: b7. DOI: 10.1016/j.jacc.2013.08.747.
TCT-157 The Effect of Smoking Status on Platelet Reactivity and Long-Term Events after PCI. Does a Clopidogrel-related "Smoker's paradox" Exist?Weisz G, Kirtane A, Xu K, Stuckey T, Witzenbichler B, Rinaldi M, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Mazzaferri E, Parise H, Mehran R, Stone G. TCT-157 The Effect of Smoking Status on Platelet Reactivity and Long-Term Events after PCI. Does a Clopidogrel-related "Smoker's paradox" Exist? Journal Of The American College Of Cardiology 2013, 62: b50. DOI: 10.1016/j.jacc.2013.08.890.
TCT-5 Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES StudyStuckey T, Kirtane A, Brodie B, Witzenbichler B, Weisz G, Rinaldi M, Neumann F, Chavez I, Metzger D, Henry T, Cox D, Duffy P, Mazzaferri E, Mehran R, Guerchicoff A, Parise H, Stone G. TCT-5 Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study. Journal Of The American College Of Cardiology 2013, 62: b2. DOI: 10.1016/j.jacc.2013.08.732.
TCT-166 Correlates of High Platelet Reactivity on Clopidogrel in 8,533 Patients: An ADAPT-DES SubstudyVaccaro B, Kirtane A, Xu K, Witzenbichler B, Weisz G, Neumann F, Rinaldi M, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Stuckey T, Mazzaferri E, Parise H, Mehran R, Stone G. TCT-166 Correlates of High Platelet Reactivity on Clopidogrel in 8,533 Patients: An ADAPT-DES Substudy. Journal Of The American College Of Cardiology 2013, 62: b53. DOI: 10.1016/j.jacc.2013.08.899.
Relationship Between Myocardial Reperfusion, Infarct Size, and Mortality The INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) TrialBrener S, Maehara A, Dizon J, Fahy M, Witzenbichler B, Parise H, El-Omar M, Dambrink J, Mehran R, Oldroyd K, Gibson C, Stone G. Relationship Between Myocardial Reperfusion, Infarct Size, and Mortality The INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) Trial. JACC Cardiovascular Interventions 2013, 6: 718-724. PMID: 23866184, DOI: 10.1016/j.jcin.2013.03.013.
Impact of Scheduled Angiographic Follow‐Up in Patients Treated With Primary Percutaneous Coronary Intervention for ST‐Segment Elevation Myocardial InfarctionMINDRESCU C, BRENER S, GUERCHICOFF A, FAHY M, PARISE H, MEHRAN R, STONE G. Impact of Scheduled Angiographic Follow‐Up in Patients Treated With Primary Percutaneous Coronary Intervention for ST‐Segment Elevation Myocardial Infarction. Journal Of Interventional Cardiology 2013, 26: 319-324. PMID: 23795656, DOI: 10.1111/joic.12038.
Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention of the Left Anterior Descending ArteryWöhrle J, Brodie B, Witzenbichler B, Dudek D, Kornowski R, Metzger C, Grines C, McAndrew T, Parise H, Sergie Z, Mehran R, Stone G. Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention of the Left Anterior Descending Artery. The American Journal Of Cardiology 2013, 112: 753-760. PMID: 23746479, DOI: 10.1016/j.amjcard.2013.05.006.
Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: The Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trialBrener S, Witzenbichler B, Maehara A, Dizon J, Fahy M, El-Omar M, Dambrink J, Genereux P, Mehran R, Oldroyd K, Parise H, Gibson C, Stone G. Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: The Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial. American Heart Journal 2013, 166: 64-70. PMID: 23816023, DOI: 10.1016/j.ahj.2013.03.029.
Objective Simulator-Based Evaluation of Carotid Artery Stenting Proficiency (from Assessment of Operator Performance by the Carotid Stenting Simulator Study [ASSESS])Weisz G, Smilowitz N, Parise H, Devaud J, Moussa I, Ramee S, Reisman M, White C, Gray W. Objective Simulator-Based Evaluation of Carotid Artery Stenting Proficiency (from Assessment of Operator Performance by the Carotid Stenting Simulator Study [ASSESS]). The American Journal Of Cardiology 2013, 112: 299-306. PMID: 23601579, DOI: 10.1016/j.amjcard.2013.02.069.
LACK OF ASSOCIATION BETWEEN ON–TREATMENT PLATELET REACTIVITY AND ISCHEMIC OUTCOMES IN DIABETIC PATIENTS: ONE YEAR RESULTS OF THE ADAPT–DES STUDYStuckey T, Kirtane A, Xu K, Witzenbichler B, Weisz G, Rinaldi M, Neumann F, Metzger C, Henry T, Cox D, Duffy P, Brodie B, Mazzaferri E, Cristea E, Parise H, Mehran R, Stone G. LACK OF ASSOCIATION BETWEEN ON–TREATMENT PLATELET REACTIVITY AND ISCHEMIC OUTCOMES IN DIABETIC PATIENTS: ONE YEAR RESULTS OF THE ADAPT–DES STUDY. Journal Of The American College Of Cardiology 2013, 61: e1737. DOI: 10.1016/s0735-1097(13)61737-4.
COMPLEMENTARY PREDICTIVE VALUE OF MYOCARDIAL BLUSH GRADE AND ST–SEGMENT RESOLUTION AFTER PRIMARY PCI: AN ANALYSIS FROM HORIZONS–AMIBrener S, Mehran R, Dizon J, McAndrew T, Parise H. COMPLEMENTARY PREDICTIVE VALUE OF MYOCARDIAL BLUSH GRADE AND ST–SEGMENT RESOLUTION AFTER PRIMARY PCI: AN ANALYSIS FROM HORIZONS–AMI. Journal Of The American College Of Cardiology 2013, 61: e1854. DOI: 10.1016/s0735-1097(13)61854-9.
A SIMPLE RISK PREDICTION SCORE FOR PATIENTS UNDERGOING MINIMALLY INVASIVE VALVE SURGERYVidi V, Reyna J, Santana O, Parise H, Lamelas J, Lamas G. A SIMPLE RISK PREDICTION SCORE FOR PATIENTS UNDERGOING MINIMALLY INVASIVE VALVE SURGERY. Journal Of The American College Of Cardiology 2013, 61: e1603. DOI: 10.1016/s0735-1097(13)61603-4.
IMPACT OF POINT–OF–CARE PLATELET FUNCTION TESTING AMONG PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROMES UNDERGOING PCI WITH DRUG–ELUTING STENTS: AN ADAPT–DES SUBSTUDYRinaldi M, Kirtane A, Xu K, Witzenbichler B, Weisz G, Neumann F, Metzger C, Henry T, Cox D, Duffy P, Brodie B, Stuckey T, Mazzaferri E, Cristea E, Parise H, Mehran R, Stone G. IMPACT OF POINT–OF–CARE PLATELET FUNCTION TESTING AMONG PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROMES UNDERGOING PCI WITH DRUG–ELUTING STENTS: AN ADAPT–DES SUBSTUDY. Journal Of The American College Of Cardiology 2013, 61: e1857. DOI: 10.1016/s0735-1097(13)61857-4.
INTRACORONARY ABCIXIMAB AND ASPIRATION THROMBECTOMY DURING PRIMARY PCI FOR ANTERIOR STEMI: ONE–YEAR RESULTS FROM THE RANDOMIZED INFUSE–AMI TRIALStone G, Maehara A, Witzenbichler B, Godlewski J, Parise H, Dambrink J, Ochala A, Carlton T, Cristea E, Wolf S, Brener S, Chowdhary S, el–omar M, Neunteufl T, Metzger C, Dizon J, Mehran R, Gibson C. INTRACORONARY ABCIXIMAB AND ASPIRATION THROMBECTOMY DURING PRIMARY PCI FOR ANTERIOR STEMI: ONE–YEAR RESULTS FROM THE RANDOMIZED INFUSE–AMI TRIAL. Journal Of The American College Of Cardiology 2013, 61: e1853. DOI: 10.1016/s0735-1097(13)61853-7.
Evaluating the clinical usefulness of platelet function testing: Considerations for the proper application and interpretation of performance measuresDahlen J, Price M, Parise H, Gurbel P. Evaluating the clinical usefulness of platelet function testing: Considerations for the proper application and interpretation of performance measures. Thrombosis And Haemostasis 2013, 109: 808-816. PMID: 23254993, DOI: 10.1160/th12-08-0608.
Response to Letter Regarding Article, “Impact of the Presence and Extent of Incomplete Angiographic Revascularization After Percutaneous Coronary Intervention in Acute Coronary SyndromesRosner G, Kirtane A, Genereux P, Lansky A, Cristea E, Weisz G, Parise H, Fahy M, Mehran R, Stone G, Gersh B. Response to Letter Regarding Article, “Impact of the Presence and Extent of Incomplete Angiographic Revascularization After Percutaneous Coronary Intervention in Acute Coronary Syndromes. Circulation 2012, 126: e295. DOI: 10.1161/circulationaha.112.137752.
Characteristics and Outcomes of Patients With ST-Segment Elevation Myocardial Infarction Excluded from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) TrialFiocca L, Guagliumi G, Rossini R, Parise H, Musumeci G, Sirbu V, Lortkipanidze N, Yu J, Mihalcsik L, Vassileva A, Valsecchi O, Gavazzi A, Mehran R, Stone G. Characteristics and Outcomes of Patients With ST-Segment Elevation Myocardial Infarction Excluded from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. The American Journal Of Cardiology 2012, 111: 196-201. PMID: 23111141, DOI: 10.1016/j.amjcard.2012.09.019.
TCT-476 Relationship Between Reference Vessel Diameter and the Incidence and Impact of Incomplete Coronary Revascularization Following PCI in ACS: The ACUITY TrialRosner G, Green P, Kirtane A, Genereux P, Lansky A, Gersh B, Weisz G, Parise H, Fahy M, Brener S, Mehran R, Stone G. TCT-476 Relationship Between Reference Vessel Diameter and the Incidence and Impact of Incomplete Coronary Revascularization Following PCI in ACS: The ACUITY Trial. Journal Of The American College Of Cardiology 2012, 60: b137-b138. DOI: 10.1016/j.jacc.2012.08.508.
TCT-513 Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI TrialDizon J, Brener S, Maehara A, Witzenbichler B, Godlewski J, Parise H, Dambrink J, Mehran R, Gibson C, Stone G. TCT-513 Simple Measures of ST-Segment Resolution Predict Infarct Size: The INFUSE-AMI Trial. Journal Of The American College Of Cardiology 2012, 60: b148-b149. DOI: 10.1016/j.jacc.2012.08.545.
TCT-486 Relationship Between White Blood Cell Count and Final Infarct Size in Patients with ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Analysis from the INFUSE-AMI TrialPalmerini T, Brener S, Dambrink J, Fahy M, Gibson C, Godlewski J, Maehara A, Ochala A, Parise H, Stone G, Witzenbichler B. TCT-486 Relationship Between White Blood Cell Count and Final Infarct Size in Patients with ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Analysis from the INFUSE-AMI Trial. Journal Of The American College Of Cardiology 2012, 60: b140. DOI: 10.1016/j.jacc.2012.08.518.
TCT-57 Angiographic Reperfusion Indices Predict Infarct Size and Mortality: The INFUSE-AMI TrialBrener S, Maehara A, Dizon J, Fahy M, Witzenbichler B, Parise H, El-Omar M, Dambrink J, Mehran R, Oldroyd K, Gibson C, Stone G. TCT-57 Angiographic Reperfusion Indices Predict Infarct Size and Mortality: The INFUSE-AMI Trial. Journal Of The American College Of Cardiology 2012, 60: b18. DOI: 10.1016/j.jacc.2012.08.068.
TCT-20 IVUS Predictors of Stent Thrombosis: Results From the Prospective, Multicenter ADAPT-DES StudyMaehara A, Mintz G, Witzenbichler B, Metzger D, Rinaldi M, Mazzaferri E, Duffy P, Weisz G, Stuckey T, Brodie B, Xu K, Parise H, Mehran R, Stone G. TCT-20 IVUS Predictors of Stent Thrombosis: Results From the Prospective, Multicenter ADAPT-DES Study. Journal Of The American College Of Cardiology 2012, 60: b6. DOI: 10.1016/j.jacc.2012.08.026.
TCT-366 Impact of gender on adverse cardiac events in patients with large anterior myocardial infarction: Results from the INFUSE-AMI trialGukathasan N, Mehran R, Brener S, Maehara A, Sergie Z, Metzger D, Oldroyd K, Parise H, Fahy M, Gibson C, Stone G. TCT-366 Impact of gender on adverse cardiac events in patients with large anterior myocardial infarction: Results from the INFUSE-AMI trial. Journal Of The American College Of Cardiology 2012, 60: b105. DOI: 10.1016/j.jacc.2012.08.393.
TCT-21 Use of IVUS Reduces Stent Thrombosis: Results from the Prospective, multicenter ADAPT-DES StudyWitzenbichler B, Maehara A, Weisz G, Neumann F, Rinaldi M, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Stuckey T, Mazzaferri E, Xu K, Mehran R, Parise H, Mintz G, Stone G. TCT-21 Use of IVUS Reduces Stent Thrombosis: Results from the Prospective, multicenter ADAPT-DES Study. Journal Of The American College Of Cardiology 2012, 60: b6-b7. DOI: 10.1016/j.jacc.2012.08.027.
TCT-467 Clinical Outcomes after Anterior ST-Elevation Myocardial Infarction According to LAD Lesion Location: The INFUSE-AMI TrialBrener S, Witzenbichler B, Maehara A, Dizon J, Fahy M, El-Omar M, Dambrink J, Mehran R, Oldroyd K, Parise H, Gibson C, Stone G. TCT-467 Clinical Outcomes after Anterior ST-Elevation Myocardial Infarction According to LAD Lesion Location: The INFUSE-AMI Trial. Journal Of The American College Of Cardiology 2012, 60: b135. DOI: 10.1016/j.jacc.2012.08.499.
Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials.Kedhi E, Stone G, Kereiakes D, Serruys P, Parise H, Fahy M, Simonton C, Sudhir K, Sood P, Smits P. Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials. EuroIntervention 2012, 8: 599-606. PMID: 22995087, DOI: 10.4244/eijv8i5a92.
Impact of major bleeding and blood transfusions after cardiac surgery: Analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trialStone G, Clayton T, Mehran R, Dangas G, Parise H, Fahy M, Pocock S. Impact of major bleeding and blood transfusions after cardiac surgery: Analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. American Heart Journal 2012, 163: 522-529. PMID: 22424026, DOI: 10.1016/j.ahj.2011.11.016.
IMPACT OF POINT-OF-CARE PLATELET FUNCTION TESTING AMONG PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROMES UNDERGOING PCI WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDYKirtane A, Rinaldi M, Parise H, Witzenbichler B, Weisz G, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Stuckey T, Mazzaferri E, Cristea E, Mehran R, Stone G. IMPACT OF POINT-OF-CARE PLATELET FUNCTION TESTING AMONG PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROMES UNDERGOING PCI WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY. Journal Of The American College Of Cardiology 2012, 59: e291. DOI: 10.1016/s0735-1097(12)60292-7.
IMPACT OF POINT-OF-CARE PLATELET FUNCTION TESTING AMONG DIABETIC AND NON-DIABETIC PATIENTS UNDERGOING PCI WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDYKirtane A, Stuckey T, Parise H, Witzenbichler B, Weisz G, Rinaldi M, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Mazzaferri E, Cristea E, Mehran R, Stone G. IMPACT OF POINT-OF-CARE PLATELET FUNCTION TESTING AMONG DIABETIC AND NON-DIABETIC PATIENTS UNDERGOING PCI WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY. Journal Of The American College Of Cardiology 2012, 59: e268. DOI: 10.1016/s0735-1097(12)60269-1.
STENT THROMBOSIS: INSIGHTS ON OUTCOMES, PREDICTORS AND IMPACT OF DUAL ANTIPLATELET THERAPY INTERRUPTION FROM THE SPIRIT II, SPIRIT III, SPIRIT IV AND COMPARE TRIALSKedhi E, Stone G, Kereiakes D, Serruys P, Parise H, Fahy M, Simonton C, Sudhir K, Sood P, Smits P. STENT THROMBOSIS: INSIGHTS ON OUTCOMES, PREDICTORS AND IMPACT OF DUAL ANTIPLATELET THERAPY INTERRUPTION FROM THE SPIRIT II, SPIRIT III, SPIRIT IV AND COMPARE TRIALS. Journal Of The American College Of Cardiology 2012, 59: e321. DOI: 10.1016/s0735-1097(12)60322-2.
DUAL ANTIPLATELET THERAPY AND LONG-TERM CLINICAL OUTCOMES AFTER PRIMARY PCI: THE HORIZONS-AMI TRIALVlachojannis G, Mehran R, Witzenbichler B, Guagliumi G, Peruga J, Brodie B, Fahy M, Kornowski R, Gersh B, Parise H, Dangas G, Stone G. DUAL ANTIPLATELET THERAPY AND LONG-TERM CLINICAL OUTCOMES AFTER PRIMARY PCI: THE HORIZONS-AMI TRIAL. Journal Of The American College Of Cardiology 2012, 59: e287. DOI: 10.1016/s0735-1097(12)60288-5.
IMPACT OF BIVALIRUDIN AND PACLITAXEL-ELUTING STENTS IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI OF THE LEFT ANTERIOR DESCENDING ARTERY: THE HORIZONS-AMI TRIALWoehrle J, Parise H, Mehran R, Stone G. IMPACT OF BIVALIRUDIN AND PACLITAXEL-ELUTING STENTS IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI OF THE LEFT ANTERIOR DESCENDING ARTERY: THE HORIZONS-AMI TRIAL. Journal Of The American College Of Cardiology 2012, 59: e280. DOI: 10.1016/s0735-1097(12)60281-2.
DOES PLATELET FUNCTION TESTING ADD SIGNIFICANT INCREMENTAL RISK STRATIFICATION TO UNSELECTED PATIENTS UNDERGOING DES IMPLANTATION? THE ADAPT-DES STUDYKirtane A, Parise H, Witzenbichler B, Weisz G, Rinaldi M, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Stuckey T, Mazzaferri E, Cristea E, Mehran R, Stone G. DOES PLATELET FUNCTION TESTING ADD SIGNIFICANT INCREMENTAL RISK STRATIFICATION TO UNSELECTED PATIENTS UNDERGOING DES IMPLANTATION? THE ADAPT-DES STUDY. Journal Of The American College Of Cardiology 2012, 59: e292. DOI: 10.1016/s0735-1097(12)60293-9.
IMPACT OF INCOMPLETE CORONARY REVASCULARIZATION ON ONE-YEAR OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN ACUTE CORONARY SYNDROMES: THE ACUITY TRIALRosner G, Kirtane A, Genereux P, Lansky A, Cristea E, Gersh B, Weisz G, Parise H, Mehran R, Stone G. IMPACT OF INCOMPLETE CORONARY REVASCULARIZATION ON ONE-YEAR OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN ACUTE CORONARY SYNDROMES: THE ACUITY TRIAL. Journal Of The American College Of Cardiology 2012, 59: e538. DOI: 10.1016/s0735-1097(12)60539-7.
Differential Clinical Responses to Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients With and Without Diabetes MellitusStone G, Kedhi E, Kereiakes D, Parise H, Fahy M, Serruys P, Smits P. Differential Clinical Responses to Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients With and Without Diabetes Mellitus. Circulation 2011, 124: 893-900. PMID: 21824922, DOI: 10.1161/circulationaha.111.031070.
Impact of Diabetes Mellitus on the Safety and Effectiveness of Bivalirudin in Patients With Acute Myocardial Infarction Undergoing Primary Angioplasty Analysis From the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) TrialWitzenbichler B, Mehran R, Guagliumi G, Dudek D, Huber K, Kornowski R, Stuckey T, Fahy M, Parise H, Stone G. Impact of Diabetes Mellitus on the Safety and Effectiveness of Bivalirudin in Patients With Acute Myocardial Infarction Undergoing Primary Angioplasty Analysis From the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) Trial. JACC Cardiovascular Interventions 2011, 4: 760-768. PMID: 21777884, DOI: 10.1016/j.jcin.2011.04.008.
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trialStone G, Witzenbichler B, Guagliumi G, Peruga J, Brodie B, Dudek D, Kornowski R, Hartmann F, Gersh B, Pocock S, Dangas G, Wong S, Fahy M, Parise H, Mehran R, Investigators O. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. The Lancet 2011, 377: 2193-2204. PMID: 21665265, DOI: 10.1016/s0140-6736(11)60764-2.
Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials.Kereiakes D, Smits P, Kedhi E, Parise H, Fahy M, Serruys P, Stone G. Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials. EuroIntervention 2011, 7: 74-83. PMID: 21550906, DOI: 10.4244/eijv7i1a14.
MINIMUM STENT AREA IS AN INDEPENDENT PREDICTOR OF ANGIOGRAPHIC RESTENOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN STEMI: A HORIZONS-AMI IVUS SUBSTUDYChoi S, Maehara A, Mintz G, Lansky A, Witzenbichler B, Guagliumi G, Brodie B, Kellett M, Dressler O, Parise H, Mehran R, Stone G. MINIMUM STENT AREA IS AN INDEPENDENT PREDICTOR OF ANGIOGRAPHIC RESTENOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN STEMI: A HORIZONS-AMI IVUS SUBSTUDY. Journal Of The American College Of Cardiology 2011, 57: e1861. DOI: 10.1016/s0735-1097(11)61861-5.
EVEROLIMUS-ELUTING VS. PACLITAXEL-ELUTING STENTS. TWO-YEAR RESULTS FROM A PATIENT-LEVEL POOLED ANALYSIS FROM THE SPIRIT II, III, IV AND COMPARE RANDOMIZED TRIALSKedhi E, Smits P, Serruys P, Kereiakes D, Parise H, Fahy M, Stone G. EVEROLIMUS-ELUTING VS. PACLITAXEL-ELUTING STENTS. TWO-YEAR RESULTS FROM A PATIENT-LEVEL POOLED ANALYSIS FROM THE SPIRIT II, III, IV AND COMPARE RANDOMIZED TRIALS. Journal Of The American College Of Cardiology 2011, 57: e1824. DOI: 10.1016/s0735-1097(11)61824-x.
IMPACT OF MAJOR BLEEDING AFTER CARDIAC SURGERY ON SUBSEQUENT MORTALITY: THE ACUITY TRIALStone G, Clayton T, Mehran R, Parise H, Fahy M, Pocock S. IMPACT OF MAJOR BLEEDING AFTER CARDIAC SURGERY ON SUBSEQUENT MORTALITY: THE ACUITY TRIAL. Journal Of The American College Of Cardiology 2011, 57: e1770. DOI: 10.1016/s0735-1097(11)61770-1.
DE NOVO CORONARY LESIONS TREATED WITH THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS: 12-MONTH ANGIOGRAPHIC RESULTS FROM THE PROSPECTIVE RANDOMIZED MULTICENTER BIOFREEDOM CLINICAL TRIALCosta R, Abizaid A, Mehran R, Magalhaes M, Gambone L, Parise H, Silva E, Schuler G, Hauptmann K, Schofer J, Grube E. DE NOVO CORONARY LESIONS TREATED WITH THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS: 12-MONTH ANGIOGRAPHIC RESULTS FROM THE PROSPECTIVE RANDOMIZED MULTICENTER BIOFREEDOM CLINICAL TRIAL. Journal Of The American College Of Cardiology 2011, 57: e1645. DOI: 10.1016/s0735-1097(11)61645-8.
COMPARISON OF LONG TERM CLINICAL PROGNOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION ACCORDING TO THE PRESENCE OF IN-HOSPITAL MAJOR BLEEDING EVENTS: 3 YEAR FOLLOW-UP RESULT OF HORIZONS-AMISuh J, Mehran R, Dangas G, Claessen B, Parise H, Lansky A, Witzenbichler B, Grines C, Guagliumi G, Kornowski R, Wohrle J, Dudek D, Weisz G, Stone G. COMPARISON OF LONG TERM CLINICAL PROGNOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION ACCORDING TO THE PRESENCE OF IN-HOSPITAL MAJOR BLEEDING EVENTS: 3 YEAR FOLLOW-UP RESULT OF HORIZONS-AMI. Journal Of The American College Of Cardiology 2011, 57: e1075. DOI: 10.1016/s0735-1097(11)61075-9.
PREDICTORS OF EARLY, LATE AND VERY LATE STENT THROMBOSIS FROM THE SPIRIT II, SPIRIT III, SPIRIT IV AND COMPARE POOLED DATA BASESmits P, Kereiakes D, Fahy M, Kedhi E, Parise H, Stone G, Ziekenhuis M. PREDICTORS OF EARLY, LATE AND VERY LATE STENT THROMBOSIS FROM THE SPIRIT II, SPIRIT III, SPIRIT IV AND COMPARE POOLED DATA BASE. Journal Of The American College Of Cardiology 2011, 57: e1765. DOI: 10.1016/s0735-1097(11)61765-8.
ARE ALL NON-CULPRIT LESIONS THAT CAUSE EVENTS SIMILAR? A PROSPECT SUBSTUDY ANALYSISSanidas E, Mintz G, Cristea E, Maehara A, de Bruyne B, Mehran R, McPherson J, Parise H, Lansky A, Templin B, Serruys P, Stone G. ARE ALL NON-CULPRIT LESIONS THAT CAUSE EVENTS SIMILAR? A PROSPECT SUBSTUDY ANALYSIS. Journal Of The American College Of Cardiology 2011, 57: e1875. DOI: 10.1016/s0735-1097(11)61875-5.
PERCUTANEOUS REVASCULARIZATION IN MULTIVESSEL CORONARY DISEASE IS IMPROVED WITH EVEROLIMUS-ELUTING STENT DEPLOYMENT: POOLED ANALYSIS FROM THE SPIRIT II IIIIV AND COMPARE TRIALSKereiakes D, Smits P, Kedhi E, Parise H, Fahy M, Serruys P, Stone G. PERCUTANEOUS REVASCULARIZATION IN MULTIVESSEL CORONARY DISEASE IS IMPROVED WITH EVEROLIMUS-ELUTING STENT DEPLOYMENT: POOLED ANALYSIS FROM THE SPIRIT II IIIIV AND COMPARE TRIALS. Journal Of The American College Of Cardiology 2011, 57: e1643. DOI: 10.1016/s0735-1097(11)61643-4.
IMPACT OF BIVALIRUDIN PROCEDURAL ANTICOAGULATION IN PATIENTS WITH DIABETES MELLITUS AND ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: 3-YEAR RESULTS FROM THE HORIZONS AMI TRIALWitzenbichler B, Mehran R, Guagliumi G, Desaga M, Kochman J, Nilsen D, Finkelstein A, Mosseri M, Parise H, Cristea E, Stone G. IMPACT OF BIVALIRUDIN PROCEDURAL ANTICOAGULATION IN PATIENTS WITH DIABETES MELLITUS AND ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: 3-YEAR RESULTS FROM THE HORIZONS AMI TRIAL. Journal Of The American College Of Cardiology 2011, 57: e1801. DOI: 10.1016/s0735-1097(11)61801-9.
STENT THROMBOSIS AFTER EVEROLIMUS-ELUTING VERSUS PACLITAXEL-ELUTING CORONARY STENTS: INSIGHTS FROM THE SPIRIT II, SPIRIT III, SPIRIT IV AND COMPARE POOLED DATABASESmits P, Kedhi E, Kereiakes D, Serruys P, Parise H, Fahy M, Stone G, Ziekenhuis M. STENT THROMBOSIS AFTER EVEROLIMUS-ELUTING VERSUS PACLITAXEL-ELUTING CORONARY STENTS: INSIGHTS FROM THE SPIRIT II, SPIRIT III, SPIRIT IV AND COMPARE POOLED DATABASE. Journal Of The American College Of Cardiology 2011, 57: e1764. DOI: 10.1016/s0735-1097(11)61764-6.
IMPACT OF ASPIRIN DOSE ON LONG TERM CLINICAL OUTCOMES AFTER STENTING FOR ACUTE MYOCARDIAL INFARCTION: 3-YEAR FOLLOW-UP DATA FROM THE HORIZONS-AMI TRIALKovacic J, Mehran R, Dangas G, Claessen B, Parise H, Fahy M, Lansky A, Witzenbichler B, Grines C, Guagliumi G, Kornowski R, Wöhrle J, Dudek D, Weisz G, Stone G. IMPACT OF ASPIRIN DOSE ON LONG TERM CLINICAL OUTCOMES AFTER STENTING FOR ACUTE MYOCARDIAL INFARCTION: 3-YEAR FOLLOW-UP DATA FROM THE HORIZONS-AMI TRIAL. Journal Of The American College Of Cardiology 2011, 57: e1633. DOI: 10.1016/s0735-1097(11)61633-1.
DISCHARGE MEDICATION USE IN PATIENTS WHO EXPERIENCE BLEEDING COMPLICATIONS AFTER PRIMARY PCI: ANALYSIS FROM HORIZONS-AMIMehran R, Claessen B, Dangas G, Suh J, Parise H, Lansky A, Witzenbichler B, Grines C, Guagliumi G, Kornowski R, Wöhrle J, Dudek D, Weisz G, Moses J, Stone G. DISCHARGE MEDICATION USE IN PATIENTS WHO EXPERIENCE BLEEDING COMPLICATIONS AFTER PRIMARY PCI: ANALYSIS FROM HORIZONS-AMI. Journal Of The American College Of Cardiology 2011, 57: e1785. DOI: 10.1016/s0735-1097(11)61785-3.
INCIDENCE AND RISK FACTORS FOR CONTRAST-INDUCED NEPHROPATHY IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION: AN ANALYSIS FROM THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION TRIAL (HORIZONS-AMI)Narula A, Weisz G, Dangas G, Clausen B, Saltzman A, Kornowski R, Brodie B, Dudek D, Nikolsky E, Witzenbichler B, Guagliumi G, Fahy M, Parise H, Stone G, Mehran R. INCIDENCE AND RISK FACTORS FOR CONTRAST-INDUCED NEPHROPATHY IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION: AN ANALYSIS FROM THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION TRIAL (HORIZONS-AMI). Journal Of The American College Of Cardiology 2011, 57: e1061. DOI: 10.1016/s0735-1097(11)61061-9.
MULTIVARIABLE PREDICTORS OF CLINICAL RESTENOSIS, CARDIAC DEATH OR MYOCARDIAL INFARCTION TO 2 YEARS FOLLOWING EVEROLIMUS OR PACLITAXEL DRUG-ELUTING STENT DEPLOYMENT: THE SPIRIT II, III, IV AND COMPARE TRIAL EXPERIENCEKereiakes D, Smits P, Kedhi E, Parise H, Fahy M, Serruys P, Stone G. MULTIVARIABLE PREDICTORS OF CLINICAL RESTENOSIS, CARDIAC DEATH OR MYOCARDIAL INFARCTION TO 2 YEARS FOLLOWING EVEROLIMUS OR PACLITAXEL DRUG-ELUTING STENT DEPLOYMENT: THE SPIRIT II, III, IV AND COMPARE TRIAL EXPERIENCE. Journal Of The American College Of Cardiology 2011, 57: e1622. DOI: 10.1016/s0735-1097(11)61622-7.
Meta-Analysis of Randomized Studies Comparing Intravascular Ultrasound Versus Angiographic Guidance of Percutaneous Coronary Intervention in Pre–Drug-Eluting Stent EraParise H, Maehara A, Stone G, Leon M, Mintz G. Meta-Analysis of Randomized Studies Comparing Intravascular Ultrasound Versus Angiographic Guidance of Percutaneous Coronary Intervention in Pre–Drug-Eluting Stent Era. The American Journal Of Cardiology 2011, 107: 374-382. PMID: 21257001, DOI: 10.1016/j.amjcard.2010.09.030.
Response to Letter Regarding Article, “Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications: Assessment From the Acute Catheterization and Urgent Intervention Triage Strategy Trial”Stone G, Mehran R, Nikolsky E, Parise H, Fahy M, Lansky A, Moses J, Pocock S, Clayton T, Bertrand M, Lincoff A, Ohman E, White H. Response to Letter Regarding Article, “Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications: Assessment From the Acute Catheterization and Urgent Intervention Triage Strategy Trial”. Circulation 2010, 122: e462-e463. DOI: 10.1161/circulationaha.110.951897.
Impact of Transfer for Primary Percutaneous Coronary Intervention on Survival and Clinical Outcomes (from the HORIZONS-AMI Trial)Wöhrle J, Desaga M, Metzger C, Huber K, Suryapranata H, Guetta V, Guagliumi G, Witzenbichler B, Parise H, Mehran R, Stone G. Impact of Transfer for Primary Percutaneous Coronary Intervention on Survival and Clinical Outcomes (from the HORIZONS-AMI Trial). The American Journal Of Cardiology 2010, 106: 1218-1224. PMID: 21029816, DOI: 10.1016/j.amjcard.2010.06.049.
THE IMPACT OF LEFT VENTRICULAR FUNCTION ON MORTALITY IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION: ANALYSIS OF THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION (HORIZONS-AMI) STUDYLansky A, Ng V, Witzenbichler B, Guagliumi G, Peruga J, Goto K, Parise H, Mehran R, Stone G. THE IMPACT OF LEFT VENTRICULAR FUNCTION ON MORTALITY IN PATIENTS WITH ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION: ANALYSIS OF THE HARMONIZING OUTCOMES WITH REVASCULARIZATION AND STENTS IN ACUTE MYOCARDIAL INFARCTION (HORIZONS-AMI) STUDY. Journal Of The American College Of Cardiology 2010, 55: a186.e1741. DOI: 10.1016/s0735-1097(10)61742-1.
IMPACT OF PACLITAXEL-ELUTING STENTS IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: ANALYSIS FROM THE HORIZONS AMI TRIALWitzenbichler B, Woehrle J, Guagliumi G, Peruga J, Brodie B, Dudek D, Kornowski R, Hartmann F, Parise H, Lansky A, Nikolsky E, Mehran R, Stone G. IMPACT OF PACLITAXEL-ELUTING STENTS IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: ANALYSIS FROM THE HORIZONS AMI TRIAL. Journal Of The American College Of Cardiology 2010, 55: a182.e1708. DOI: 10.1016/s0735-1097(10)61709-3.
PATIENTS ADMITTED WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND A NORMAL OR NEAR NORMAL CORONARY ANGIOGRAM HAVE A FAVORABLE PROGNOSIS: ANALYSIS FROM HORIZONS-AMI TRIALLarsen A, Nilsen D, Nikolsky E, Lansky A, Caixeta A, Parise H, Fahy M, Criatea E, Witzenbichler B, Guagliumi G, Peruga J, Brodie B, Dudek D, Mehran R, Stone G. PATIENTS ADMITTED WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND A NORMAL OR NEAR NORMAL CORONARY ANGIOGRAM HAVE A FAVORABLE PROGNOSIS: ANALYSIS FROM HORIZONS-AMI TRIAL. Journal Of The American College Of Cardiology 2010, 55: a187.e1746. DOI: 10.1016/s0735-1097(10)61747-0.
IMPACT OF GENDER ON THE EXTENT OF CORONARY ATHEROSCLEROSIS AND PLAQUE CHARACTERIZATION IN ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE PROSPECT TRIALLansky A, Maehara A, Mintz G, Ng V, Veldhof S, de Bruyne B, McPherson J, Cristea E, Templin B, Parise H, Fahy M, Serruys P, Stone G. IMPACT OF GENDER ON THE EXTENT OF CORONARY ATHEROSCLEROSIS AND PLAQUE CHARACTERIZATION IN ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE PROSPECT TRIAL. Journal Of The American College Of Cardiology 2010, 55: a186.e1738. DOI: 10.1016/s0735-1097(10)61739-1.
PRELIMINARY ANGIOGRAPHIC RESULTS OF THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS FOR THE TREATMENT OF CORONARY ARTERY LESIONS - FOUR-MONTH ANGIOGRAPHIC FOLLOW-UP OF THE PROSPECTIVE, RANDOMIZED, MULTICENTER BIOFREEDOM TRIALCosta R, Abizaid A, Mehran R, Lansky A, Magalhaes M, Gambone L, Parise H, Schuler G, Hauptmann K, Schofer J, Grube E. PRELIMINARY ANGIOGRAPHIC RESULTS OF THE NOVEL POLYMER-FREE BIOLIMUS-A9 COATED STENTS FOR THE TREATMENT OF CORONARY ARTERY LESIONS - FOUR-MONTH ANGIOGRAPHIC FOLLOW-UP OF THE PROSPECTIVE, RANDOMIZED, MULTICENTER BIOFREEDOM TRIAL. Journal Of The American College Of Cardiology 2010, 55: a192.e1801. DOI: 10.1016/s0735-1097(10)61802-5.
IMPACT OF INTRAVENOUS HEPARIN ADMINISTERED PRIOR TO PRIMARY PERCUTANEOUS CORONARY INTERVENTION: ANALYSIS FROM THE HORIZONS-AMI TRIALNikolsky E, Mehran R, Dangas G, Lansky A, Rabbani L, Guagliumi G, Kornowski R, Hartmann F, Fahy M, Witzenbichler B, Peruga J, Gambone L, Parise H, Stone G. IMPACT OF INTRAVENOUS HEPARIN ADMINISTERED PRIOR TO PRIMARY PERCUTANEOUS CORONARY INTERVENTION: ANALYSIS FROM THE HORIZONS-AMI TRIAL. Journal Of The American College Of Cardiology 2010, 55: a185.e1729. DOI: 10.1016/s0735-1097(10)61730-5.
IVUS PREDICTORS OF EARLY STENT THROMBOSIS AFTER PRIMARY PERCUTANEOUS INTERVENTION IN ACUTE MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDYChoi S, Witzenbichler B, Maehara A, Mintz G, Lansky A, Guagliumi G, Brodie B, Kellett M, Parise H, Mehran R, Dangas G, Stone G. IVUS PREDICTORS OF EARLY STENT THROMBOSIS AFTER PRIMARY PERCUTANEOUS INTERVENTION IN ACUTE MYOCARDIAL INFARCTION: A HORIZONS-AMI SUBSTUDY. Journal Of The American College Of Cardiology 2010, 55: a182.e1703. DOI: 10.1016/s0735-1097(10)61704-4.
Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty Results From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) TrialDangas G, Mehran R, Guagliumi G, Caixeta A, Witzenbichler B, Aoki J, Peruga J, Brodie B, Dudek D, Kornowski R, Rabbani L, Parise H, Stone G, Investigators H. Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty Results From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial. Journal Of The American College Of Cardiology 2009, 54: 1438-1446. PMID: 19796737, DOI: 10.1016/j.jacc.2009.06.021.
Abstract 4505: Presentation To Non-PCI Center Is Major Modifiable Factor Associated With Delayed Door-to-balloon Time In HORIZONS-AMIBlankenship J, Scott T, Skelding K, Berger P, Parise H, Brodie B, Witzenberger B, Gaugliumi G, Peruga J, Lansky A, Mehran R, Stone G. Abstract 4505: Presentation To Non-PCI Center Is Major Modifiable Factor Associated With Delayed Door-to-balloon Time In HORIZONS-AMI. Circulation 2008, 118 DOI: 10.1161/circ.118.suppl_18.s_903.
Abstract 4589: Anti-thrombotic Strategies in Patients with Elevated Biomarkers Undergoing PCI: Results from the ACUITY TrialBrar S, McLaurin B, Cox D, Bertrand M, Lincoff A, Moses J, White H, Ohman E, Mehran R, Lansky A, Parise H, Stone G. Abstract 4589: Anti-thrombotic Strategies in Patients with Elevated Biomarkers Undergoing PCI: Results from the ACUITY Trial. Circulation 2008, 118 DOI: 10.1161/circ.118.suppl_18.s_917-a.
Abstract 5608: Prognostic Impact of the Baseline White Blood Cell Count in Patients with Acute Myocardial Infarction Undergoing Primary PCI: Results from the HORIZONS-AMI trialMehran R, Dangas G, Parise H, Guagliumi G, Witzenbichler B, Grinfeld L, Peruga J, Kornowski R, Dudek D, Hoard R, Kastrati A, Herzzentrum D, Brar S, Wu R, Fiscella D, Brodie B, Lansky A, Stone G. Abstract 5608: Prognostic Impact of the Baseline White Blood Cell Count in Patients with Acute Myocardial Infarction Undergoing Primary PCI: Results from the HORIZONS-AMI trial. Circulation 2008, 118 DOI: 10.1161/circ.118.suppl_18.s_973-b.
Abstract 2564: Predictors of Early Stent Thrombosis in Patients with Acute Coronary Syndromes in the Drug-Eluting Stent Era: Analysis from the ACUITY trialAoki J, Stone G, Mehran R, Moses J, Bertrand M, Lincoff A, Ohman E, White H, Parise H, Leon M, Lansky A. Abstract 2564: Predictors of Early Stent Thrombosis in Patients with Acute Coronary Syndromes in the Drug-Eluting Stent Era: Analysis from the ACUITY trial. Circulation 2007, 116 DOI: 10.1161/circ.116.suppl_16.ii_567-b.
Associations of Plasma Natriuretic Peptide, Adrenomedullin, and Homocysteine Levels With Alterations in Arterial StiffnessLevy D, Hwang S, Kayalar A, Benjamin E, Vasan R, Parise H, Larson M, Wang T, Selhub J, Jacques P, Vita J, Keyes M, Mitchell G. Associations of Plasma Natriuretic Peptide, Adrenomedullin, and Homocysteine Levels With Alterations in Arterial Stiffness. Circulation 2007, 115: 3079-3085. PMID: 17533184, DOI: 10.1161/circulationaha.106.652842.
Pulse Pressure and Risk of New-Onset Atrial FibrillationMitchell G, Vasan R, Keyes M, Parise H, Wang T, Larson M, D’Agostino R, Kannel W, Levy D, Benjamin E. Pulse Pressure and Risk of New-Onset Atrial Fibrillation. JAMA 2007, 297: 709-715. PMID: 17312290, DOI: 10.1001/jama.297.7.709.
Phenotype-genotype association grid: a convenient method for summarizing multiple association analysesLevy D, DePalma S, Benjamin E, O'Donnell C, Parise H, Hirschhorn J, Vasan R, Izumo S, Larson M. Phenotype-genotype association grid: a convenient method for summarizing multiple association analyses. BMC Genomic Data 2006, 7: 30. PMID: 16716207, PMCID: PMC1526453, DOI: 10.1186/1471-2156-7-30.
Cross-Sectional Association of Kidney Function with Valvular and Annular Calcification: The Framingham Heart StudyFox C, Larson M, Vasan R, Guo C, Parise H, Levy D, Leip E, O’Donnell C, D’Agostino R, Benjamin E. Cross-Sectional Association of Kidney Function with Valvular and Annular Calcification: The Framingham Heart Study. Journal Of The American Society Of Nephrology 2005, 17: 521-527. PMID: 16382018, DOI: 10.1681/asn.2005060627.
Cross-Sectional Relations of Peripheral Microvascular Function, Cardiovascular Disease Risk Factors, and Aortic StiffnessMitchell G, Vita J, Larson M, Parise H, Keyes M, Warner E, Vasan R, Levy D, Benjamin E. Cross-Sectional Relations of Peripheral Microvascular Function, Cardiovascular Disease Risk Factors, and Aortic Stiffness. Circulation 2005, 112: 3722-3728. PMID: 16330686, DOI: 10.1161/circulationaha.105.551168.
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes MellitusWilson P, D’Agostino R, Parise H, Sullivan L, Meigs J. Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus. Circulation 2005, 112: 3066-3072. PMID: 16275870, DOI: 10.1161/circulationaha.105.539528.
Obesity and the Risk of New-Onset Atrial Fibrillation—ReplyWang T, Parise H, Sullivan L, D’Agostino R, Levy D, Wolf P, Vasan R, Benjamin E. Obesity and the Risk of New-Onset Atrial Fibrillation—Reply. JAMA 2005, 293: 1974-1975. PMID: 15855424, DOI: 10.1001/jama.293.16.1975-a.
Response: Flow-Mediated Dilation: Just a Marker of Local Shear Stress?Mitchell G, Warner E, Parise H, Vita J, Keaney J, Keyes M, Levy D, Larson M, Vasan R, Benjamin E. Response: Flow-Mediated Dilation: Just a Marker of Local Shear Stress? Hypertension 2005, 45: e11-e12. PMID: 15642771, DOI: 10.1161/01.hyp.0000154362.35209.b9.
Response: Flow-Mediated Dilation: Just a Marker of Local Shear Stress?Mitchell G, Warner E, Parise H, Vita J, Keaney J, Keyes M, Levy D, Larson M, Vasan R, Benjamin E. Response: Flow-Mediated Dilation: Just a Marker of Local Shear Stress? Hypertension 2005 DOI: 10.1161/01.hyp.0000154363.70993.2b.
Obesity and the Risk of New-Onset Atrial FibrillationWang T, Parise H, Levy D, D’Agostino R, Wolf P, Vasan R, Benjamin E. Obesity and the Risk of New-Onset Atrial Fibrillation. JAMA 2004, 292: 2471-2477. PMID: 15562125, DOI: 10.1001/jama.292.20.2471.
Local Shear Stress and Brachial Artery Flow–Mediated DilationMitchell G, Parise H, Vita J, Larson M, Warner E, Keaney J, Keyes M, Levy D, Vasan R, Benjamin E. Local Shear Stress and Brachial Artery Flow–Mediated Dilation. Hypertension 2004, 44: 134-139. PMID: 15249547, DOI: 10.1161/01.hyp.0000137305.77635.68.
Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham StudyFreedman D, Otvos J, Jeyarajah E, Shalaurova I, Cupples L, Parise H, D’Agostino R, Wilson P, Schaefer E. Sex and Age Differences in Lipoprotein Subclasses Measured by Nuclear Magnetic Resonance Spectroscopy: The Framingham Study. Clinical Chemistry 2004, 50: 1189-1200. PMID: 15107310, DOI: 10.1373/clinchem.2004.032763.
Parental Atrial Fibrillation as a Risk Factor for Atrial Fibrillation in OffspringFox C, Parise H, D'Agostino R, Lloyd-Jones D, Vasan R, Wang T, Levy D, Wolf P, Benjamin E. Parental Atrial Fibrillation as a Risk Factor for Atrial Fibrillation in Offspring. JAMA 2004, 291: 2851-2855. PMID: 15199036, DOI: 10.1001/jama.291.23.2851.
Changes in Arterial Stiffness and Wave Reflection With Advancing Age in Healthy Men and WomenMitchell G, Parise H, Benjamin E, Larson M, Keyes M, Vita J, Vasan R, Levy D. Changes in Arterial Stiffness and Wave Reflection With Advancing Age in Healthy Men and Women. Hypertension 2004, 43: 1239-1245. PMID: 15123572, DOI: 10.1161/01.hyp.0000128420.01881.aa.
The replyRoubenoff R, Parise H. The reply. The American Journal Of Medicine 2004, 116: 642. DOI: 10.1016/j.amjmed.2003.12.028.
Asthma, wheezing, and allergies in Russian schoolchildren in relation to new surface materials in the home.Jaakkola J, Parise H, Kislitsin V, Lebedeva N, Spengler J. Asthma, wheezing, and allergies in Russian schoolchildren in relation to new surface materials in the home. American Journal Of Public Health 2004, 94: 560-2. PMID: 15054004, PMCID: PMC1448297, DOI: 10.2105/ajph.94.4.560.
Housing characteristics and children's respiratory health in the Russian Federation.Spengler J, Jaakkola J, Parise H, Katsnelson B, Privalova L, Kosheleva A. Housing characteristics and children's respiratory health in the Russian Federation. American Journal Of Public Health 2004, 94: 657-62. PMID: 15054021, PMCID: PMC1448314, DOI: 10.2105/ajph.94.4.657.
Mitral annular calcification is a predictor for incident atrial fibrillationFox C, Parise H, Vasan R, Levy D, O’Donnell C, D’Agostino R, Plehn J, Benjamin E. Mitral annular calcification is a predictor for incident atrial fibrillation. Atherosclerosis 2004, 173: 291-294. PMID: 15064104, DOI: 10.1016/j.atherosclerosis.2003.12.018.
Influence of negative factors of the living environment on respiratory diseases in children.Lebedeva N, Furman V, Kislitsa V, Konygin E, Zemlianaia G, Koroleva M, Jaakkola J, Parise H, Spengler J. Influence of negative factors of the living environment on respiratory diseases in children. Hygiene And Sanitation 2004, 59-65. PMID: 15197863.
Impact of building and finishing materials and new furniture on the occurrence of respiratory diseases in children.Lebedeva N, Furman V, Kislitsin V, Konygin E, Zemlianaia G, Koroleva M, Jaakkola J, Parise H, Spengler J. Impact of building and finishing materials and new furniture on the occurrence of respiratory diseases in children. Hygiene And Sanitation 2004, 49-53. PMID: 15318615.
Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart StudyRoubenoff R, Parise H, Payette H, Abad L, D'Agostino R, Jacques P, Wilson P, Dinarello C, Harris T. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. The American Journal Of Medicine 2003, 115: 429-435. PMID: 14563498, DOI: 10.1016/j.amjmed.2003.05.001.
Mitral Annular Calcification Predicts Cardiovascular Morbidity and MortalityFox C, Vasan R, Parise H, Levy D, O’Donnell C, D’Agostino R, Benjamin E. Mitral Annular Calcification Predicts Cardiovascular Morbidity and Mortality. Circulation 2003, 107: 1492-1496. PMID: 12654605, DOI: 10.1161/01.cir.0000058168.26163.bc.
Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and FunctionRutter M, Parise H, Benjamin E, Levy D, Larson M, Meigs J, Nesto R, Wilson P, Vasan R. Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function. Circulation 2003, 107: 448-454. PMID: 12551870, DOI: 10.1161/01.cir.0000045671.62860.98.
Overweight and Obesity as Determinants of Cardiovascular Risk: The Framingham ExperienceWilson P, D'Agostino R, Sullivan L, Parise H, Kannel W. Overweight and Obesity as Determinants of Cardiovascular Risk: The Framingham Experience. JAMA Internal Medicine 2002, 162: 1867-1872. PMID: 12196085, DOI: 10.1001/archinte.162.16.1867.
Insulin resistance is associated with left ventricular remodeling: the framingham heart studyRutter M, Parise H, Larson M, Benjamin E, Levy D, Meigs J, Nesto R, Wilson P, Vasan R. Insulin resistance is associated with left ventricular remodeling: the framingham heart study. Journal Of The American College Of Cardiology 2002, 39: 207. DOI: 10.1016/s0735-1097(02)80917-2.
Flexible Estimates of Tumour Incidence for Intermediately Lethal Tumours in a Typical Long-Term Animal BioassayParise H, Dinse G, Ryan L. Flexible Estimates of Tumour Incidence for Intermediately Lethal Tumours in a Typical Long-Term Animal Bioassay. Journal Of The Royal Statistical Society Series C (Applied Statistics) 2001, 50: 171-185. DOI: 10.1111/1467-9876.00227.
Incorporation of Historical Controls Using Semiparametric Mixed ModelsParise H, Wand M, Ruppert D, Ryan L. Incorporation of Historical Controls Using Semiparametric Mixed Models. Journal Of The Royal Statistical Society Series C (Applied Statistics) 2001, 50: 31-42. DOI: 10.1111/1467-9876.00218.

Edit Profile

Contact Information

Research & Publications

Biography

News

Coauthors

Selected Publications